A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures.
Pavel KleinJimmy SchiemannMichael R SperlingJohn WhitesidesWei LiangTracy StalveyChristian BrandtPatrick KwanPublished in: Epilepsia (2015)
Adjunctive BRV 100 and 200 mg/day was efficacious in reducing POS in adults without concomitant levetiracetam use and was well tolerated.